Market Place
Sourcing Support
FDA approves four oligonucleotide therapies in 2023; Novartis, GSK, Novo bet big
In the intricate world of molecular biology, oligonucleotides stand out as versatile, powerful molec
New Drugs Approvals by FDA and EMA: 2020 Recap
The year
2020 was an eventful year for the pharmaceutical industry, with several
companies across
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
